text: Dermatologic manifestations of COVID 19 associated multisystem inflammatory syndrome in children Multisystem inflammatory syndrome in children MIS C affects a small percentage of pediatric patients infected with COVID 19 and is characterized by fever laboratory evidence of inflammation multisystem involvement and severe illness necessitating hospitalization Skin findings are often present in these patients and when initially compared with Kawasaki disease they likely represent distinct phenomena and overall remain poorly characterized In this retrospective review of 34 case reports and series we identified cutaneous manifestations documented in 417 of 736 patients 57 with MIS C associated with COVID 19 Rash was the sole descriptor of skin findings in nearly half of patients Case reports and smaller case series provided more detail outlining a broad range of lesion morphologies polymorphic maculopapular morbilliform erythrodermic urticarial reticular petechial purpuric in variable anatomic distribution More thorough descriptions of dermatologic manifestations in patients with MIS C are warranted to better characterize this syndrome as they may lend important insight into pathogenic mechanisms of disease 